NO20003096D0 - Sammensetninger og fremgangsmÕter for behandling av ADD - Google Patents

Sammensetninger og fremgangsmÕter for behandling av ADD

Info

Publication number
NO20003096D0
NO20003096D0 NO20003096A NO20003096A NO20003096D0 NO 20003096 D0 NO20003096 D0 NO 20003096D0 NO 20003096 A NO20003096 A NO 20003096A NO 20003096 A NO20003096 A NO 20003096A NO 20003096 D0 NO20003096 D0 NO 20003096D0
Authority
NO
Norway
Prior art keywords
compositions
methods
treating add
treating
add
Prior art date
Application number
NO20003096A
Other languages
English (en)
Other versions
NO329974B1 (no
NO20003096L (no
Inventor
Juan Mantelle
Terese A Dixon
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26750154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003096(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Noven Pharma filed Critical Noven Pharma
Publication of NO20003096D0 publication Critical patent/NO20003096D0/no
Publication of NO20003096L publication Critical patent/NO20003096L/no
Publication of NO329974B1 publication Critical patent/NO329974B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
NO20003096A 1997-12-15 2000-06-15 Sammensetning for topisk applikasjon av metylfenidat, og anvendelse av metylfenidat i fremstillingen av et fleksibelt, endelig system for behandling av ADHD og ADD. NO329974B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6951097P 1997-12-15 1997-12-15
US09/163,351 US6210705B1 (en) 1997-12-15 1998-09-30 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
PCT/US1998/026560 WO1999030694A2 (en) 1997-12-15 1998-12-14 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate

Publications (3)

Publication Number Publication Date
NO20003096D0 true NO20003096D0 (no) 2000-06-15
NO20003096L NO20003096L (no) 2000-08-15
NO329974B1 NO329974B1 (no) 2011-01-31

Family

ID=26750154

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003096A NO329974B1 (no) 1997-12-15 2000-06-15 Sammensetning for topisk applikasjon av metylfenidat, og anvendelse av metylfenidat i fremstillingen av et fleksibelt, endelig system for behandling av ADHD og ADD.

Country Status (28)

Country Link
US (2) US6210705B1 (no)
EP (2) EP2314288B1 (no)
JP (3) JP4316800B2 (no)
KR (1) KR100633348B1 (no)
CN (1) CN1368876A (no)
AR (1) AR014062A1 (no)
AT (1) ATE260652T1 (no)
AU (1) AU752027B2 (no)
BR (1) BR9814282A (no)
CA (1) CA2315237C (no)
CZ (2) CZ300535B6 (no)
DE (1) DE69822199T2 (no)
DK (1) DK1037615T3 (no)
ES (2) ES2219926T3 (no)
HK (1) HK1049447A1 (no)
HU (1) HU226615B1 (no)
IL (1) IL136760A0 (no)
LV (1) LV12558B (no)
NO (1) NO329974B1 (no)
NZ (1) NZ505689A (no)
PE (1) PE20000120A1 (no)
PL (1) PL195315B1 (no)
PT (1) PT1037615E (no)
RU (1) RU2233156C2 (no)
SI (1) SI20360B (no)
TR (1) TR200001736T2 (no)
TW (2) TWI244396B (no)
WO (1) WO1999030694A2 (no)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US20020102291A1 (en) * 1997-12-15 2002-08-01 Noven Pharmaceuticals, Inc. Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
GB9913458D0 (en) * 1999-06-09 1999-08-11 Medeva Europ Ltd The therapeutic use of d-threo-methylphenidate
GB9918735D0 (en) * 1999-08-09 1999-10-13 Straken Limited Transdermal patches
CO5261532A1 (es) * 1999-11-15 2003-03-31 Novartis Ag Compuestos heterociclicos sililados, procedimiento para la preparacion de estos y composicion farmaceutica que los contiene
WO2001043730A2 (en) * 1999-12-17 2001-06-21 Medeva Europe Limited The treatment of convulsive states
US6455066B1 (en) 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
US7674480B2 (en) * 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
DE10060550C1 (de) * 2000-12-06 2002-04-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
KR100846642B1 (ko) * 2001-03-07 2008-07-16 히사미쓰 세이야꾸 가부시키가이샤 첩부제
FR2822049B1 (fr) * 2001-03-13 2003-08-01 Dbv Medica 1 Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation
MXPA03008349A (es) * 2001-03-16 2004-10-15 Johnson & Johnson Parche transdermico para administrar fentanilo.
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20030049272A1 (en) * 2001-08-30 2003-03-13 Yatindra Joshi Pharmaceutical composition which produces irritation
JP4354678B2 (ja) * 2002-08-28 2009-10-28 久光製薬株式会社 貼付剤
US6913768B2 (en) 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
EP1575569B1 (en) 2002-12-13 2010-09-29 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
CN100457064C (zh) * 2003-10-28 2009-02-04 诺芬药品公司 透皮递药装置
CA2595400C (en) 2005-01-20 2017-01-17 Institute For Molecular Medicine, Inc. Methylphenidate derivatives and their use in the treatment of angiogenic diseases and conditions
EP1845780B1 (en) * 2005-01-20 2011-07-27 Institute for Molecular Medicine, Inc. Uses of methylphenidate derivatives
WO2007077029A1 (de) * 2005-12-23 2007-07-12 Epinamics Gmbh Verwendung filmbildender haarpflegepolymere aus der gruppe der polyurethane und diese polymere enthaltende pharmazeutische zubereitungen und pflaster
US9393218B2 (en) * 2005-12-23 2016-07-19 Epinamics Gmbh Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
MX2008010934A (es) * 2006-02-27 2008-10-30 Noven Pharma Sistema terapeutico transdermico que contiene escopolamina.
AU2007248284B2 (en) * 2006-05-01 2011-03-17 Colgate-Palmolive Company Oral care composition with silicone composite
WO2008103538A1 (en) * 2007-02-21 2008-08-28 Connected Health Systems, Llc Treating adhd and other diseases involving inflammation
CN104398496B (zh) * 2007-10-15 2018-03-20 阿尔扎公司 芬太尼的一天更换一次透皮施用
FR2924350B1 (fr) * 2007-12-03 2010-08-13 Dbv Tech Procede et compositions pour la vaccination par voie cutanee
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
EP2219622A1 (en) 2007-12-06 2010-08-25 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
EP2234652B1 (en) * 2007-12-31 2014-09-24 Acclarent, Inc. Mucosal tissue dressing and method of use
FR2926466B1 (fr) * 2008-01-23 2010-11-12 Dbv Tech Procede de fabrication de patchs par electrospray
US8217047B2 (en) * 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
JP5155128B2 (ja) * 2008-12-11 2013-02-27 日東電工株式会社 メチルフェニデート貼付製剤
WO2010141587A1 (en) * 2009-06-05 2010-12-09 Megtec Systems, Inc. Improved infrared float bar
EP2364695A1 (en) 2010-02-10 2011-09-14 Nitto Denko Corporation Methylphenidate patch preparation
US20110200663A1 (en) * 2010-02-12 2011-08-18 Nitto Denko Corporation Methylphenidate patch preparation
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
ES2973539T3 (es) 2011-03-23 2024-06-20 Ironshore Pharmaceuticals & Dev Inc Métodos y composiciones para el tratamiento del trastorno por déficit de atención
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
HRP20170555T1 (hr) 2011-07-28 2017-06-16 Kempharm, Inc. Metilfenidatni prolijekovi, postupci za njihovo dobivanje i njihova primjena
US9717697B2 (en) 2012-10-15 2017-08-01 Noven Pharmaceuticals, Inc. Compositions and methods for the transdermal delivery of methylphenidate
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
ES2864327T3 (es) 2012-12-28 2021-10-13 Noven Pharma Composiciones de múltiples polímeros para la administración transdérmica de fármacos
TW201431554A (zh) 2012-12-28 2014-08-16 Noven Pharma 左炔諾孕酮（ｌｅｖｏｎｏｒｇｅｓｔｒｅｌ）及乙烯雌二醇之經皮藥物遞送系統
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
US11337936B2 (en) 2013-03-14 2022-05-24 Noven Pharmaceuticals, Inc. Amphetamine transdermal compositions with acrylic block copolymer
JP2016515523A (ja) 2013-03-15 2016-05-30 デュレクト コーポレーション 溶解変動性を低減させるためのレオロジー改質剤を有する組成物
AR095260A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
AR095259A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
US9782383B2 (en) 2013-12-25 2017-10-10 Fujimoto Co., Ltd. Prophylactic and therapeutic agent for attention-deficit/hyperactivity disorder
US9980921B2 (en) * 2016-06-30 2018-05-29 Taho Pharmaceuticals Ltd. Transdermal delivery system containing methylphenidate or its salts and methods thereof
MY205229A (en) 2016-07-06 2024-10-08 Durect Corp Oral dosage form with drug composition, barrier layer and drug layer
CN106511264A (zh) * 2016-11-15 2017-03-22 北京万全德众医药生物技术有限公司 一种盐酸哌甲酯口服溶液剂及其制备方法
ES2979262T3 (es) 2016-12-11 2024-09-25 Zevra Therapeutics Inc Composiciones que comprenden metilfenidato-profármacos, procesos de elaboración y uso de las mismas
EP3598982A1 (en) 2018-07-23 2020-01-29 Centre National De La Recherche Scientifique Bioconjugates of neuropeptides derivatives
JP7600661B2 (ja) * 2020-12-11 2024-12-17 ａｒｔｉｅｎｃｅ株式会社 貼付剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957880A (en) 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
US4310509A (en) 1979-07-31 1982-01-12 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesive having a broad spectrum antimicrobial therein
US4655767A (en) 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3910578A1 (de) * 1989-03-29 1990-10-04 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
JP2693212B2 (ja) * 1989-03-28 1997-12-24 日東電工株式会社 疾患治療用テープ製剤
WO1992021333A2 (en) * 1991-05-24 1992-12-10 Pharmavene, Inc. Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors
US5629019A (en) 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
ATE152630T1 (de) 1992-07-28 1997-05-15 Procter & Gamble Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
CH691209A5 (de) 1993-09-06 2001-05-15 Scherrer Inst Paul Herstellungsverfahren für einen Polmerelektrolyten und elektrochemische Zelle mit diesem Polymerelektrolyten.
ES2139778T3 (es) 1994-06-29 2000-02-16 Hennecke Gmbh Procedimiento y dispositivo para la fabricacion continua de bloques o bandas de material de espuma.
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5780050A (en) 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
AU2590697A (en) 1997-03-07 1998-09-22 Richard R. Jackson Anesthetizing plastics, drug delivery plastics, and related medical products, s ystems and methods
GB9711032D0 (en) 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
EP1710506A2 (en) 1999-12-15 2006-10-11 Osaka Gas Co., Ltd. Burner Apparatus, Gas Turbine Engine and Cogeneration System

Also Published As

Publication number Publication date
LV12558A (lv) 2000-11-20
CZ2009132A3 (cs) 2016-03-23
IL136760A0 (en) 2001-06-14
HUP0004539A2 (hu) 2001-06-28
HU226615B1 (en) 2009-04-28
NO329974B1 (no) 2011-01-31
EP2314288A1 (en) 2011-04-27
WO1999030694A2 (en) 1999-06-24
EP2314288B1 (en) 2013-12-11
PT1037615E (pt) 2004-07-30
US6210705B1 (en) 2001-04-03
HK1049447A1 (zh) 2003-05-16
HUP0004539A3 (en) 2006-06-28
AU752027B2 (en) 2002-09-05
TW200406231A (en) 2004-05-01
DE69822199T2 (de) 2005-02-17
AU1824999A (en) 1999-07-05
LV12558B (en) 2001-03-20
TWI242452B (en) 2005-11-01
NO20003096L (no) 2000-08-15
KR100633348B1 (ko) 2006-10-16
BR9814282A (pt) 2000-10-03
CZ305817B6 (cs) 2016-03-23
ATE260652T1 (de) 2004-03-15
EP1037615B1 (en) 2004-03-03
ES2452517T3 (es) 2014-04-01
KR20010033114A (ko) 2001-04-25
EP1037615A2 (en) 2000-09-27
ES2219926T3 (es) 2004-12-01
JP2013056944A (ja) 2013-03-28
PL341596A1 (en) 2001-04-23
US6348211B1 (en) 2002-02-19
AR014062A1 (es) 2001-01-31
TWI244396B (en) 2005-12-01
CA2315237A1 (en) 1999-06-24
WO1999030694A3 (en) 1999-08-19
JP2009073856A (ja) 2009-04-09
PL195315B1 (pl) 2007-08-31
NZ505689A (en) 2003-01-31
CN1368876A (zh) 2002-09-11
JP2002510600A (ja) 2002-04-09
RU2233156C2 (ru) 2004-07-27
TR200001736T2 (tr) 2001-01-22
SI20360A (sl) 2001-04-30
DK1037615T3 (da) 2004-07-12
PE20000120A1 (es) 2000-02-19
CZ20002209A3 (cs) 2000-11-15
SI20360B (sl) 2008-06-30
DE69822199D1 (de) 2004-04-08
HK1156872A1 (en) 2012-06-22
CA2315237C (en) 2009-12-01
CZ300535B6 (cs) 2009-06-10
JP4316800B2 (ja) 2009-08-19

Similar Documents

Publication Publication Date Title
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO991676D0 (no) FremgangsmÕter og sammensetninger for immunmodulering
NO20012916D0 (no) Sammensetninger og fremgangsmåter for behandling av anorektale forstyrrelser
DE69834401D1 (de) Businterfacesystem und verfahren
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
ATE351910T1 (de) Ob-fusionsprotein enthaltende zusammensetzungen und verfahren
EP1014995A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING RESTENOSES CONSECUTIVE TO REVASCULARIZATION INTERVENTIONS
NO994481D0 (no) Sammensetninger og fremgangsmÕter for redusering av okulær hypertensjon
NO20006488D0 (no) Sammensetning og anvendelse
NO20005017D0 (no) Metoder og viskøse sammensetninger for behandling av brønner
DK0804078T3 (da) Sammensætning og anvendelse deraf
PT956294E (pt) Inibidores da trombina
DE69904731D1 (de) Feinzerkleinerer und feinzerkleinerungsverfahren
NO985385L (no) Bitumensammensetninger og fremgangsmÕte for fremstilling derav
ZA981600B (en) Methods and compositions for treating stickies
NO996090L (no) Forbedret foskefor og fremgangsmåte for anvendelse av dette
PT948483E (pt) Inibidores da farnesil-transferase
DE69924489D1 (de) Getreide-beta-glukanzusammensetzungen und verfahren
FI965008L (fi) Koostumukset ja menetelmät kasvainten hoitamiseksi
ID19570A (id) Metode merawat tanaman kotiledonous
EP1073333A4 (en) S-RABEPRAZOLE COMPOSITIONS AND METHODS
ATE209195T1 (de) Naphthylverbindungen und zusammensetzungen
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO964485D0 (no) Fremgangsmåte for stabilisering av forbindelsen DX-52-1 og lyofilisert sammensetning derav
ID16838A (id) Komposisi dekafluoropentana

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees